Advertising regulation is widespread in healthcare. Health practitioners often have defined limitations to professional advertising through regulation and their professional associations. Advertising standards for drugs with marketing authorisation are usually regulated to higher standards than in other industries both by voluntary self regulation and legislation.
- ↑ Tanne JH. Merck pays $1bn penalty in relation to promotion of rofecoxib. BMJ (Clinical research ed.). 2011; 343:d7702.(Epub)
- ↑ Hawkes N. GlaxoSmithKline pays $3bn to settle dispute over rosiglitazone and other drugs. BMJ (Clinical research ed.). 2011; 343:d7234.(Epub)
- ↑ Harris, Gardiner (September 3, 2009). "Pfizer Pays $2.3 billion to Settle Marketing Case". The New York Times.